BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7073268)

  • 1. Pharmacokinetics of ceforanide.
    Ripa S; La Rosa F; Ghezzi A; Prenna M; Pfeffer M
    Antimicrob Agents Chemother; 1982 Feb; 21(2):323-6. PubMed ID: 7073268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intramuscular ceforanide in infants, children, and adolescents.
    Dajani AS; Thirumoorthi MC; Bawdon RE; Buckley JA; Pfeffer M; Van Harken DR; Smyth RD
    Antimicrob Agents Chemother; 1982 Feb; 21(2):282-7. PubMed ID: 7073266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceforanide kinetics.
    Estey EH; Weaver SS; LeBlanc BM; Brown N; Ho DH; Bodey GP
    Clin Pharmacol Ther; 1981 Sep; 30(3):396-403. PubMed ID: 7273604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmacokinetics of a new braod-spectrum parenteral cephalosporin antibiotic, ceforanide.
    Pfeffer M; Gaver RC; Van Harken DR
    J Pharm Sci; 1980 Apr; 69(4):398-403. PubMed ID: 7373533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.
    Lee FH; Pfeffer M; Van Harken DR; Smyth RD; Hottendorf GH
    Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of ceftizoxime compared with that of cefamandole.
    Neu HC; Srinivasan S
    Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats.
    Lee FH; Smyth RD; Van Harken DR
    Antimicrob Agents Chemother; 1981 Apr; 19(4):625-7. PubMed ID: 7247385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceforanide kinetics in renal insufficiency.
    Hawkins SS; Alford RH; Stone WJ; Smyth RD; Pfeffer M
    Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.
    Hess JR; Berman SJ; Boughton WH; Sugihara JG; Musgrave JE; Wong EG; Siemsen AM
    Antimicrob Agents Chemother; 1980 Feb; 17(2):251-3. PubMed ID: 7387145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary levels of ceforanide.
    Kenady DE; Ram MD
    Antimicrob Agents Chemother; 1983 May; 23(5):706-9. PubMed ID: 6870219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery.
    Mullany LD; French MA; Nightingale CH; Low HB; Ellison LH; Quintiliani R
    Antimicrob Agents Chemother; 1982 Mar; 21(3):416-20. PubMed ID: 7103445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.
    Smyth RD; Pfeffer M; Glick A; Van Harken DR; Hottendorf GH
    Antimicrob Agents Chemother; 1979 Nov; 16(5):615-21. PubMed ID: 526003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous cephamandole pharmacokinetics and intramuscular bioavailability in neonates.
    Buchanan N; Doyle P; Cvejic M
    Aust Paediatr J; 1981 Jun; 17(2):83-4. PubMed ID: 7305773
    [No Abstract]   [Full Text] [Related]  

  • 17. Ceforanide: antibacterial activity, pharmacology, and clinical efficacy.
    Barriere SL; Mills J
    Pharmacotherapy; 1982; 2(6):322-7. PubMed ID: 6762529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of probenecid to alter the pharmacokinetics of ceforanide.
    Jovanovich JF; Saravolatz LD; Burch K; Pohlod DJ
    Antimicrob Agents Chemother; 1981 Oct; 20(4):530-2. PubMed ID: 7342878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ceforanide in the treatment of childhood infections.
    Thirumoorthi MC; Buckley JA; Vincent CV; Kobos D; Dajani AS
    Pediatr Infect Dis; 1983; 2(5):377-80. PubMed ID: 6634466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of cefamandole in newborn infants.
    Agbayani MM; Khan AJ; Kemawikasit P; Rosenfeld W; Salazar D; Kumar K; Glass L; Evans HE
    Antimicrob Agents Chemother; 1979 May; 15(5):674-6. PubMed ID: 525985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.